Cardiogen (Cardiogen (Ala-Glu-Asp-Arg Cardiac Bioregulator))
A short synthetic peptide bioregulator from the Khavinson family targeted at cardiac (myocardial) tissue. It is used in the bioregulator community to support heart muscle function and cardiovascular resilience in short repeated courses.
How it works
As a signal peptide (Ala-Glu-Asp-Arg), it is proposed to regulate gene expression in myocardial tissue, supporting cardiomyocyte function, myocardial protein synthesis, and normal cardiac tissue maintenance.
Key facts
- Molecular weight: ~460 Da
- Half-life: Short (peptide)
- Bioavailability: Oral (encapsulated) or subcutaneous
- Storage: Room temperature (capsules) or refrigerate (injectable).
Dosing overview
- Typical dose: ~1-2 capsules/day or short injectable courses
- Frequency: Once daily
- Duration: 10-30 day courses
- Route: Oral capsule or subcutaneous
Protocol notes
- Taken as short repeatable courses (often 10-30 days), a few times per year.
- Oral encapsulated forms are taken once daily on an empty stomach.
- Frequently paired with vascular bioregulators in cardiovascular protocols.
Reported benefits
- Cardiac/myocardial tissue support
- Cardiovascular resilience (proposed)
- Myocardial protein synthesis support
- Short course-based protocol
Possible side effects
- Limited Western clinical data
- Injection site reactions (injectable)
- Unknown long-term effects
Research
- Cardiac peptide bioregulators (2016): Reported to support myocardial tissue function and protein synthesis in regional research studies.
Community reviews of Cardiogen
- morning_protocol rated it 5/5 - Genuinely effective after 2 months: Been using Cardiogen for about 2 months and the results are clear. Not overnight dramatic, but a steady, consistent improvement that became undeniable by the end of the first month. The mechanism makes sense based on what I have read in the literature, and my subjective experience matches the expected timeline. Benefits built gradually and plateaued at a good level. Side effects were minimal to none at the dose I used. Followed proper protocols for sourcing, storage, and administration. Would recommend to others who have done their research and have realistic expectations.
- steady_state_stan rated it 4/5 - Worth adding to the protocol: Cardiogen has been a worthwhile addition. I am data-driven and tracked relevant markers before, during, and after. The improvement is measurable and correlates with the intervention timeline. What sets this apart from some compounds I have tried is the consistency. Benefits did not fluctuate wildly or disappear. They built up and maintained. That gives me confidence in the mechanism. Tolerance has been excellent. Nothing in my bloodwork or subjective experience raised any flags. This is the kind of compound that does its job quietly without causing problems. Exactly what you want.
- deep_science_dee rated it 5/5 - Noticed clear benefits within weeks: Added Cardiogen to my protocol about 2 months ago and it has earned its place. The benefits became noticeable around week 2-3 and have been consistent since. What I appreciate about this compound is the predictability. It does what the research suggests it should do, at roughly the timeline you would expect. No surprises, no dramatic swings, just steady improvement. No notable side effects to report at my dose. Sourcing is always the challenge with research compounds, insist on third-party testing. Storage and reconstitution per standard protocols. Plan to continue.
Compare Cardiogen
Community discussions about Cardiogen
- Injection site irritation and mild chest tightness with short‑course Cardiogen - 4 comments
- Cardiogen injection site bruising after repeated courses - 9 comments
- Cardiogen injections: mild injection site pain and what I did to ease it - 6 comments
- Ask the community about Cardiogen
Research and educational reference only. Not medical advice.